http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014132159-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-81
filingDate 2013-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2014132159-A
titleOfInvention COMPOUNDS OF 2-ARILBENZOFURAN-7-FORMAMID, METHOD FOR PRODUCING AND USE
abstract 1. The compound 2-aryl-benzofuran-7-carboxamide of the general formula I or a pharmacologically or physiologically acceptable salt where R and R are each independently H, straight or branched C-C1-6 alkyl, C-C-cycloalkyl or saturated 5- or 6 a-membered heterocyclic group containing O or N; or R and R together with N form an unsubstituted or substituted, saturated 5- or 6-membered heterocyclic group containing at least one heteroatom, where the heteroatom is O, N and S, the substituent is methyl on N; Rpr dstavlyaet a hydrogen atom or a chlorine atom; R represents a hydrogen atom or a fluorine atom; X represents CH, CF or N; and Y represents CH, CF, or N.2. The compound or a pharmacologically or pharmaceutically acceptable salt thereof according to claim 1, wherein R is H, methyl, ethyl, isopropyl, cyclopropyl, piperidin-4-yl or (R) tetrahydrofuran-3-yl; R is H, methyl, ethyl, isopropyl , cyclopropyl, piperidin-4-yl or (R) tetrahydrofuran-3-yl; or R and R together with N form unsubstituted or substituted morpholinyl, piperazinyl, homopiperazinyl, thiomorpholinyl, piperidinyl or pyrrolidinyl, where the substituent is methyl on N; Rpred hydrogen; R represents a fluorine atom; X represents spin precession is a CH, CF or N; and Y represents CH, CF, or N.3. The compound or a pharmacologically or physiologically acceptable salt thereof according to claim 2, wherein R is H or methyl; R is methyl, isopropyl, cyclopropyl, piperidin-4-yl or (R) tetrahydrofuran-3-yl; or R and R together with N form an unsubstituted or substituted morpholinyl, piperazinyl, homopiperazinyl, thiomorpholinyl, piperidinyl or pyrrolidinyl, where the substituent is methyl
priorityDate 2012-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457517809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420237462

Total number of triples: 36.